Characterization of cardiovascular endpoints, impact of event adjudication and effects of darapladib in the STABILITY trial
Publication
, Conference
Held, C; White, HD; Stewart, RAH; Davies, R; Sampson, SH; Chiswell, K; Boden, U; Mahaffey, KW; Wallentin, L
Published in: EUROPEAN HEART JOURNAL
August 1, 2015
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2015
Volume
36
Start / End Page
1104 / 1104
Location
London, ENGLAND
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Held, C., White, H. D., Stewart, R. A. H., Davies, R., Sampson, S. H., Chiswell, K., … Wallentin, L. (2015). Characterization of cardiovascular endpoints, impact of event adjudication and effects of darapladib in the STABILITY trial. In EUROPEAN HEART JOURNAL (Vol. 36, pp. 1104–1104). London, ENGLAND: OXFORD UNIV PRESS.
Held, C., H. D. White, R. A. H. Stewart, R. Davies, S. H. Sampson, K. Chiswell, U. Boden, K. W. Mahaffey, and L. Wallentin. “Characterization of cardiovascular endpoints, impact of event adjudication and effects of darapladib in the STABILITY trial.” In EUROPEAN HEART JOURNAL, 36:1104–1104. OXFORD UNIV PRESS, 2015.
Held C, White HD, Stewart RAH, Davies R, Sampson SH, Chiswell K, et al. Characterization of cardiovascular endpoints, impact of event adjudication and effects of darapladib in the STABILITY trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 1104–1104.
Held, C., et al. “Characterization of cardiovascular endpoints, impact of event adjudication and effects of darapladib in the STABILITY trial.” EUROPEAN HEART JOURNAL, vol. 36, OXFORD UNIV PRESS, 2015, pp. 1104–1104.
Held C, White HD, Stewart RAH, Davies R, Sampson SH, Chiswell K, Boden U, Mahaffey KW, Wallentin L. Characterization of cardiovascular endpoints, impact of event adjudication and effects of darapladib in the STABILITY trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 1104–1104.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2015
Volume
36
Start / End Page
1104 / 1104
Location
London, ENGLAND
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology